RESONANCE
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Resonance Specialties Says Dividend Of 1 Rupee Per Share
May 11 (Reuters) - Resonance Specialties Ltd RESP.BO:
DIVIDEND OF 1 RUPEE PER SHARE
Source text for Eikon: ID:nBSE94QPsr
Further company coverage: RESP.BO
(([email protected];))
May 11 (Reuters) - Resonance Specialties Ltd RESP.BO:
DIVIDEND OF 1 RUPEE PER SHARE
Source text for Eikon: ID:nBSE94QPsr
Further company coverage: RESP.BO
(([email protected];))
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Resonance Specialtie do?
Resonance Specialties, operating since 1989, is a leader in Pyridine chemistry, manufacturing products like Pyridine, Picoline, and derivatives. Their ISO certified plant in India adheres to GMP guidelines, ensuring top-quality production.
Who are the competitors of Resonance Specialtie?
Resonance Specialtie major competitors are Par Drugs & Chem., Archit Organosys, Alkali Metals, Polson, IVP, AG Ventures, Kanchi Karpooram. Market Cap of Resonance Specialtie is ₹117 Crs. While the median market cap of its peers are ₹154 Crs.
Is Resonance Specialtie financially stable compared to its competitors?
Resonance Specialtie seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Resonance Specialtie pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Resonance Specialtie latest dividend payout ratio is 17.58% and 3yr average dividend payout ratio is 20.33%
How has Resonance Specialtie allocated its funds?
Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable
How strong is Resonance Specialtie balance sheet?
Balance sheet of Resonance Specialtie is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Resonance Specialtie improving?
Yes, profit is increasing. The profit of Resonance Specialtie is ₹7.61 Crs for TTM, ₹6.57 Crs for Mar 2025 and ₹2.97 Crs for Mar 2024.
Is the debt of Resonance Specialtie increasing or decreasing?
Yes, The debt of Resonance Specialtie is increasing. Latest debt of Resonance Specialtie is ₹1.88 Crs as of Mar-25. This is greater than Mar-24 when it was -₹0.2 Crs.
Is Resonance Specialtie stock expensive?
Resonance Specialtie is not expensive. Latest PE of Resonance Specialtie is 15.33, while 3 year average PE is 22.92. Also latest EV/EBITDA of Resonance Specialtie is 10.8 while 3yr average is 15.48.
Has the share price of Resonance Specialtie grown faster than its competition?
Resonance Specialtie has given better returns compared to its competitors. Resonance Specialtie has grown at ~21.0% over the last 6yrs while peers have grown at a median rate of 13.76%
Is the promoter bullish about Resonance Specialtie?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Resonance Specialtie is 54.25% and last quarter promoter holding is 54.25%.
Are mutual funds buying/selling Resonance Specialtie?
There is Insufficient data to gauge this.